- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/32 - Antioestrogens
Patent holdings for IPC class A61P 5/32
Total number of patents in this class: 76
10-year publication summary
|
4
|
5
|
8
|
3
|
3
|
3
|
3
|
8
|
5
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Forendo Pharma Ltd. | 18 |
5 |
| Sanofi | 4320 |
5 |
| Bayer Pharma AG | 1010 |
3 |
| FUJIFILM Corporation | 30562 |
3 |
| Novartis AG | 10178 |
2 |
| Bayer Schering Pharma AG | 311 |
2 |
| DSM IP Assets B.V. | 5385 |
2 |
| Dr. Reddy's Laboratories, Inc. | 158 |
2 |
| Dr. Reddy's Laboratories Limited | 555 |
2 |
| Endorecherche, Inc. | 21 |
2 |
| Olema Pharmaceuticals, Inc. | 72 |
2 |
| Solvay Pharmaceuticals GmbH | 7 |
2 |
| Universite Laval | 710 |
2 |
| Inventisbio LLC | 42 |
2 |
| The Regents of the University of California | 20802 |
1 |
| Janssen Pharmaceutica N.V. | 3161 |
1 |
| Pfizer Inc. | 3404 |
1 |
| Bayer Intellectual Property GmbH | 2357 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
1 |
| The Board of Trustees of the University of Illinois | 2748 |
1 |
| Other owners | 34 |